Electrical storm in patients with implantable cardioverter-defibrillators: can it be forecast?
- PMID: 20069082
- PMCID: PMC2801945
Electrical storm in patients with implantable cardioverter-defibrillators: can it be forecast?
Abstract
The aim of this retrospective study was to determine the prevalence and predictors of electrical storm in 227 patients who had received implantable cardioverter-defibrillators (ICDs) and had been monitored for 31.7 +/- 15.6 months. Of these, 174 (77%) were men. The mean age was 55.8 +/- 15.5 years (range, 20-85 yr), and the mean left ventricular ejection fraction (LVEF) was 0.30 +/- 0.14. One hundred forty-six of the patients (64%) had underlying coronary artery disease. Cardioverter-defibrillators were implanted for secondary (80%) and primary (20%) prevention. Of the 227 patients, 117 (52%) experienced events that required ICD therapy. Thirty patients (mean age, 57.26 +/- 14.3 yr) had > or = 3 episodes requiring ICD therapy in a 24-hour period and were considered to have electrical storm. The mean number of events was 12.75 +/- 15 per patient. Arrhythmia-clustering occurred an average of 6.1 +/- 6.7 months after ICD implantation. Clinical variables with the most significant association with electrical storm were low LVEF (P = 0.04; hazard ratio of 0.261, and 95% confidence interval of 0.08-0.86) and higher use of class IA antiarrhythmic drugs (P = 0.018, hazard ratio of 3.84, and 95% confidence interval of 1.47-10.05). Amiodarone treatment and use of beta-blockers were not significant predictors when subjected to multivariate analysis. We conclude that electrical storm is most likely to occur in patients with lower LVEF and that the use of Class IA antiarrhythmic drugs is a risk factor.
Keywords: Antiarrhythmia agents; arrhythmias, cardiac/prevention & control; cardiac pacing, artificial; defibrillators, implantable; electric countershock; electrical storm; heart failure; tachycardia, ventricular/therapy; ventricular dysfunction, left.
Figures


Similar articles
-
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28. J Cardiovasc Electrophysiol. 2012. PMID: 21955243
-
Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.J Am Coll Cardiol. 1998 Dec;32(7):1909-15. doi: 10.1016/s0735-1097(98)00495-1. J Am Coll Cardiol. 1998. PMID: 9857871
-
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.Circulation. 2001 Apr 24;103(16):2066-71. doi: 10.1161/01.cir.103.16.2066. Circulation. 2001. PMID: 11319196
-
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. doi: 10.1016/s0002-9149(99)00040-5. Am J Cardiol. 1999. PMID: 10089848 Review.
-
Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator.Postgrad Med J. 2015 Sep;91(1079):519-26. doi: 10.1136/postgradmedj-2015-133550. Epub 2015 Aug 26. Postgrad Med J. 2015. PMID: 26310265 Review.
Cited by
-
Electrical storm - still an extremely poor prognosis. Do these acute states of life-threatening arrhythmias require a multidirectional approach from the start?Postepy Kardiol Interwencyjnej. 2019;15(1):1-12. doi: 10.5114/aic.2019.83769. Epub 2019 Apr 4. Postepy Kardiol Interwencyjnej. 2019. PMID: 31043979 Free PMC article. Review.
-
Management of monomorphic ventricular tachycardia electrical storm in structural heart disease.J Saudi Heart Assoc. 2019 Jul;31(3):135-144. doi: 10.1016/j.jsha.2019.05.001. Epub 2019 May 11. J Saudi Heart Assoc. 2019. PMID: 31198398 Free PMC article. Review.
-
The evaluation and management of electrical storm.Tex Heart Inst J. 2011;38(2):111-21. Tex Heart Inst J. 2011. PMID: 21494516 Free PMC article. Review.
References
-
- Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877–83. - PubMed
-
- Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators [published erratum appears in N Engl J Med 2000;342(17):1300]. N Engl J Med 1999;341(25):1882–90. - PubMed
-
- A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337 (22):1576–83. - PubMed
-
- Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92(1):59–65. - PubMed
-
- Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R, et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996;93(4):753–62. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical